Prior Auth Tied to Delays, Discontinuation of Cancer Meds

The introduction of a new prior authorization requirement for an established oral anticancer regimen led to more treatment delays and discontinuations among Medicare beneficiaries.
Medscape Medical News

source https://www.medscape.com/viewarticle/new-prior-auth-policy-tied-delays-discontinuation-oral-2024a100009g?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?